Matsukiyococokara & Co.

Matsukiyococokara took revenue up 5.7% to ¥289.3bn in April–June 2026, operating profit up 8.5% to ¥21.5bn and net income up 14.9% to ¥14.9bn. Japan's largest drugstore group is also one of the largest single destinations for visitor spending — cosmetics and medicines are consistently among the categories inbound shoppers buy most — which makes it the cleanest listed read on that demand outside the department stores themselves. Full-year guidance stands at ¥1,155.0bn revenue (+3.4%).